• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | Inspections
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameAVITENE(R) MICROFIBRILLAR COLLAGEN HEMOSTAT (MCH)
Classification Nameagent, absorbable hemostatic, collagen based
Generic Nameabsorbable hemostatic agents, collagen based
Regulation Number878.4490
ApplicantDAVOL, INC., SUB. C.R. BARD, INC.
PMA NumberN17600
Supplement NumberS015
Date Received07/21/1998
Decision Date08/10/1998
Product Code
LMF[ Registered Establishments with LMF ]
Advisory Committee General & Plastic Surgery
Supplement Type30-day notice
Supplement Reason process change: manufacturing
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Requested the elimination of the in-vivo hemostasis test, a heavy metals test done at an intermediate bulk stage of avitene mch flur, and the routine performance of finished product sterility testing as part of the sterilization release criteria for each lot of product sterilized.
-
-